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Abstract
Chronic occupational exposure to benzene is associated with an increased risk of hematological malignancies such as acute
myeloid leukemia (AML), but the underlying mechanisms are still unclear. The main objective of this study was to
investigate the association between benzene exposure and DNA methylation, both in repeated elements and candidate
genes, in a population of 158 Bulgarian petrochemical workers and 50 unexposed office workers. Exposure assessment
included personal monitoring of airborne benzene at work and urinary biomarkers of benzene metabolism (S-
phenylmercapturic acid [SPMA] and trans,trans-muconic acid [t,t-MA]) at the end of the work-shift. The median levels of
airborne benzene, SPMA and t,t-MA in workers were 0.46 ppm, 15.5 mg/L and 711 mg/L respectively, and exposure levels
were significantly lower in the controls. Repeated-element DNA methylation was measured in Alu and LINE-1, and gene-
specific methylation in MAGE and p15. DNA methylation levels were not significantly different between exposed workers
and controls (P.0.05). Both ordinary least squares (OLS) and beta-regression models were used to estimate benzene-
methylation associations. Beta-regression showed better model specification, as reflected in improved coefficient of
determination (pseudo R2) and Akaike’s information criterion (AIC). In beta-regression, we found statistically significant
reductions in LINE-1 (20.15%, P,0.01) and p15 (20.096%, P,0.01) mean methylation levels with each interquartile range
(IQR) increase in SPMA. This study showed statistically significant but weak associations of LINE-1 and p15 hypomethylation
with SPMA in Bulgarian petrochemical workers. We showed that beta-regression is more appropriate than OLS regression
for fitting methylation data.
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Introduction
Benzene is a known human carcinogen classified by the
International Agency for Research on Cancer (IARC) as a Group
I carcinogen due to sufficient evidence for causing acute myeloid
leukemia (AML) in humans [1]. It has also been associated with
other diseases of the blood-forming systems such as myelodysplas-
tic syndromes (MDS), lymphocytic leukemias and other cancers
[2–5]. Some of the major current exposures to benzene occur in
petrochemical industries, coke and steel plants, and from traffic
exhaust and cigarettes smoke. Following findings on the effects of
low-dose occupational exposure to benzene, such as hematotoxic
effects seen at levels as low as 1 ppm [6], whether there is a safe
level of occupational benzene exposure has been highly debated.
Once absorbed into the body, benzene is metabolized to benzene
oxide before forming either S-phenylmercapturic acid (SPMA) or
trans,trans-muconic acid (t,t-MA) in the liver and lungs [7]. SPMA
and t,t-MA are the most commonly used biomarkers of
occupational benzene exposure [8–10]. The exact mechanism by
which benzene exerts its toxicity still remains unclear.
Aberrant DNA methylation, which may lead to genomic
instability and altered gene expression, is frequently observed in
AML [11]. Repeated-element DNA hypomethylation, as well as
gene-specific hypermethylation or hypomethylation are commonly
seen in hematological cancers [12]. Hypermethylation of tumor
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suppressor p15, which leads to inactivation of the gene and
subsequent uncontrolled proliferation of the cell, is commonly
observed in AML and other hematological cancers [13–16]. The
melanoma antigen family A (MAGE) gene, which encodes tumor-
rejection antigens, is widely expressed in cells from hematological
malignancies and is found to be hypomethylated with benzene
exposure [17–20]. Studies have found significant correlation
between SPMA and 8-oxo-29-deoxyguanosine (8-oxodG) – a
biomarker of oxidative DNA damage – measured in lymphocytes,
which may then induce epigenetic modifications [21,22].
To date, most studies have performed statistical analyses of
DNA methylation using ordinary least squares (OLS) regression, in
which the Gaussian distribution is assumed for the methylation
level. However, methylation is usually measured as percentage or
proportion values (%5 mC), which are bounded in the (0,1)
interval. In principle, the beta distribution, as opposed to the
Gaussian distribution, would be the most natural statistical model
for analyzing proportional data bounded in the (0,1) interval [23]
and has also been shown in many empirical studies, to be an
appropriate distributional model for proportion data where most
of the linear assumptions tend to fail [24]. Beta regression has been
proven to be more flexible than OLS regression, as it uses two sets
of parameters to model trends in both the conditional mean and
the precision (hence, conditional variance) of the proportion data
distributed over the (0,1) interval with respect to a set of
explanatory covariates [25]. However, whether a beta distribution
is more appropriate to fit methylation data has yet not been
evaluated on empirical data.
The main objective of this study was to investigate possible
mechanisms of benzene toxicity via DNA methylation, by
examining both repeated-element and gene-specific DNA meth-
ylation in a population of Bulgarian petrochemical workers. We
also explored using beta-regression models to fit the methylation
data as a methodological alternative to more commonly used OLS
regression. Since DNA methylation is potentially modifiable
through lifestyle or pharmacological intervention, identifying the
association between benzene and methylation may be critical to
identify biological effects from benzene exposure and design public
health interventions among exposed workers.
Materials and Methods
Ethics Statement
Written informed consent was obtained prior to enrollment.
The study was approved by the Genoa, Italy National Cancer
Research Institute Ethics Committees.
Study Population
The study population consisted of 158 petrochemical workers
employed at the Lukoil-Neftochim petrochemical plant in Burgas,
Bulgaria and 50 unexposed office workers, used as controls, from
the same plant. All subjects were recruited between October 1999
and September 2000 and had worked in the same position at the
plant for at least one year. Self-administered questionnaires
collected information regarding exposure history, medical history,
lifestyle factors, smoking habits, occupational activities and other
personal information.
Benzene Exposure Assessment
Individual airborne benzene measurements were based on
personal monitoring sampling on the day before phlebotomy.
Personal exposure to airborne benzene was measured by active
sampling using charcoal sampling tubes as described previously
[26]. Briefly, personal full-shift air monitoring was performed
during one working day using active samplers with flow of 20–30
cm3/min worn near the breathing zone during a typical work-shift
(midweek, from 8:00 a.m. to 2:00 p.m.), and analyzed with a
Perkin Elmer Model 8300 gas chromatograph with flame-
ionization detector and column DB-1–30 m. The limit of
detection (LOD) for benzene was 0.023 ppm for the whole sample
volume.
In addition to air benzene, urinary biomarkers of benzene
exposure, i.e., S-phenylmercapturic acid (SPMA) and trans-trans-
muconic acid (t,t-MA), which represent intermediary metabolites
of benzene metabolism, were also assessed. Both biomarkers were
measured in urine samples collected at the end of the work shift in
the same day of air monitoring using previously-described
methods [26,27]. Briefly, determination of urinary t,t-MA was
performed by pre-purification of urine with solid-phase extraction
using a strong-anion exchange column (SAX, 300 mg, Supelco
Analytical, St. Louis, MO) followed by high performance liquid
chromatography and UV detection as reported by Buratti and
colleagues [28]. The LOD for t,t-MA was 50 mg/l, and forty-six
measurements below LOD were assigned a value corresponding to
half of LOD (i.e. 25 mg/l) with thirty-three (71.7%) of them being
controls. Determination of urinary SPMA was based on an
immunoassay technique according to a previously published
procedure [29]. The immunoassay plate-based kit and reagents
were from AB Biomonitoring Ltd. (Cardiff, Wales, United
Kingdom). The detection limit of the procedure was 0.2 mg/L
and none of the measurements were below LOD.
Methylation Outcomes
Four ml of whole blood was collected in EDTA tubes from each
subject. DNA was extracted using the Wizard Genomic DNA
purification kit (Promega, Madison, WI, USA) following the
manufacturer’s instructions. We performed DNA methylation
analyses on bisulfite-treated DNA using a highly-quantitative
analysis based on PCR-Pyrosequencing. 500 ng DNA (concentra-
tion 25 ng/ml) was treated using the EZ DNA Methylation-
GoldTM Kit (Zymo Research, Orange, CA, USA) according to the
manufacturer’s protocol. Final elution was performed with 200 ml
M-Elution Buffer. We performed DNA methylation analyses of
Alu and LINE-1 repeated sequences, which allow for the
amplification of a representa-tive pool of repetitive elements, as
previously described [17].
To measure methylation of the MAGE and p15 promoters, a
50 mL PCR was carried out in 25 mL GoTaq Green Master mix
(Promega, Madison, WI, USA), 25 ng bisulfite-treated genomic
DNA, with primer concentrations and PCR cycling conditions for
each assay as shown in Table S1. PCR products were purified and
sequenced by pyrosequencing as previously described using
0.3 mM sequencing primer [17]. PCR primers are shown in
Table S2. Compared to other common methods of DNA
methylation analysis, pyrosequencing-based assays have the
advantage of producing individual measures of methylation at
more than one CpG dinucleotide, thus more accurately reflecting
DNA methylation in the region. In each gene promoter assay, we
measured %5 mC at different CpG dinucleotides within the
promoter region as shown in Table S3. Every sample was
pyrosequenced two times for each assay to confirm reliability and
the average of the two runs was used in the statistical analysis.
Statistical Analysis
Demographic, exposure and methylation variables were com-
pared between workers and controls using Pearson’s chi-square
test for categorical variables, Welch two-sample t-test for normally-
distributed continuous variables and Wilcoxon’s rank sum test for
Urinary Benzene Biomarkers and DNA Methylation
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non-normally distributed continuous variables. First, simple linear
ordinary least squares (OLS) models were fitted to Alu, LINE-1,
MAGE, and p15 methylation levels as dependent variables with
each of the exposure variables separately. Additional multiple
linear regression models were fitted that adjusted for the set of
potential confounders of age, sex, current smoking habits, daily
hours of environmental tobacco smoke (ETS) exposure and
education level. Since DNA methylation was measured in white
blood cells, and each white blood cell subtype may have different
methylation profiles [30], we also measured proportions of the
various leukocyte cell types (basophils, eosinophils, lymphocytes,
monocytes and neutrophils) and adjusted for all analyses in order
to eliminate influences from differences in proportions of cell types
(Table S4). We then fit a second set of models using beta-
regression [31]. We hypothesized that the beta-regression
approach to be more appropriate and potentially provide more
statistical power than OLS regression for methylation data, which
are measured as proportions ranging from 0 to 1 (reported here, as
customary, as percent values). Both the conditional mean and the
precision (hence, conditional variance) of each methylation
variable were modeled with the same set of covariates using the
logit link for the conditional mean response and the log link for the
conditional precision. The estimates from all models are reported
as ‘increase in percent methylation per IQR increase in exposure’
in order to make the associations in the different models
comparable for all exposure variables. Fitted mean methylation
level trajectories for an individual with average characteristics (40
years old, non-smoking male worker with middle-school education
and 5.3 ETS [Environmental Tobacco Smoking] hours) were
plotted to provide a graphical representation of the results.
Regular adjusted (for OLS) and pseudo adjusted (for beta
regression) coefficients of determination (R2), as well as Akaike’s
information criterion (AIC) were also computed for each of the
adjusted models in order to compare relative goodness of fit
between OLS and beta regression models. We also generated
Pearson residual plots to compare model fit (Figures S1 and S2).
All statistical analyses were conducted using the betareg and base
packages in R version 2.13.1 (R-project.org.  1998–2012) All
tests were conducted as two-sided and considered significant with a
p-value ,0.05.
Results
The study participants were predominantly male and most of
the individual characteristics were similar in both workers and
controls (Table 1). However, education level was significantly
lower in workers as compared to controls (P,0.001). ETS hours
were significantly higher in workers compared to controls
(P,0.001). Therefore both education and ETS hours were
adjusted for in our regression models.
All exposure indices were significantly higher in workers than
controls (Table 2). Median air benzene levels for controls were not
calculated as almost all of the controls, except for one, were
exposed to benzene levels below the limit of detection (LOD). Both
urinary SPMA and t,t-MA were significantly higher among the
workers (all P,0.001). Median SPMA levels were approximately
15.5 mg/L among workers and 10.1 mg/L among controls, and
median t,t-MA levels were 711 mg/L among workers and 25 mg/L
among controls. The correlation between the three different
exposure variables in workers was moderate: 0.23 between
airborne log-benzene and SPMA (P,0.001); 0.40 between the
two biomarkers SPMA and t,t-MA (P,0.001); and 0.48 between
airborne log-benzene and t,t-MA (P,0.001). We found no
statistically significant difference between workers and controls in
the four methylation outcome variables as shown in Table 2.
Because all of the controls except for one had air benzene below
LOD, we did not use air benzene in the regression models
reported below.
Table 3 presents the OLS regression results for the association
between percent methylation of each methylation variable with
each urinary biomarker. The magnitudes of association estimates
were expressed as % change in DNA methylation per an IQR
increase in the exposure biomarkers. Using urinary SPMA as
exposure, we found small but statistically significant decreases in
the methylation levels of both LINE-1 (20.089% per IQR
increase, P=0.035) and p15 (20.090% per IQR increase,
P= 0.048) with increasing SPMA in the unadjusted model. Only
LINE-1 was significant when adjusted for all other covariates.
LINE-1 methylation level was reduced by 0.14% (P=0.009) with
each IQR increase in urinary SPMA exposure after adjusting for
age, sex, education, smoking and ETS hours. There were no
significant associations with t,t-MA. Adjusting for the possible
effects that may be due to inherent between-participant differences
in relative proportions of the various leukocyte cell types (Table
S4) did not alter the results, so heterogeneity in leukocyte cell type
was not included in the final model.
Table 4 shows the beta-regression results for the association
between percent methylation of each methylation variable with
each of the two urinary exposure variables. Using unadjusted beta-
regression models, we found statistically significant but modest
reductions in LINE-1 (0.085%, P=0.033) and in p15 (0.084%,
P=0.023) methylation levels with each IQR increase in urinary
SPMA. After adjusting for all of the covariates, both LINE-1 and
p15 remained significant; we found a significant 0.15% decrease in
LINE-1 (P=0.005), and 0.096% decrease in p15 (P=0.001)
methylation per an IQR increase in urinary SPMA. Significant
associations were not observed with t,t-MA. Scatterplots showing
SPMA and each of the methylation markers, as well as regression
lines from beta-regression models are shown in Figure 1.
In general, the results from beta-regression were overall
consistent with those from OLS regression. However, beta-
regression models had higher adjusted pseudo R2 values and
lower AICs as compared to those generated by OLS regression
models (Tables 3 and 4), indicating that beta regression performed
better, in terms of model fit, than OLS regression models. We note
that for the association of MAGE methylation with both SPMA
and t,t-MA, OLS regression models showed negative adjusted R2
values, which indicate particularly inadequate fit to the methyl-
ation data [32,33]. In addition, Pearson residual plots showed that
beta regression generally provides better fit of the data (Figures S1
and S2).
Discussion
In this study, we investigated the association between occupa-
tional benzene exposure with both repeated-element and gene-
specific DNA methylation in a population of Bulgarian petro-
chemical workers. Using beta-regression, we found small but
statistically significant associations of LINE-1 and p15 hypomethy-
lation with SPMA after adjusting for covariates. We also showed
that beta-regression provided better goodness-of-fit, as reflected in
higher adjusted pseudo R2 and lower AIC values, compared to
standard linear OLS regression models. Our results show that
exposure to benzene, as reflected in the internal dose measured by
urinary SPMA was associated with both repeated-element and
gene-specific hypomethylation.
Our finding showing a decrease in LINE-1 methylation with
increasing urinary SPMA levels in beta-regression models is
Urinary Benzene Biomarkers and DNA Methylation
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consistent with the global hypomethylation reported in response to
various environmental exposures [17,34–38] and has been
suggested to represent an early step preceding the severe
hypomethylation typical of leukemia and other malignancies
[12,39–42]. The observed association was small in size, consistent
with previous results by Bollati et al. in a study of gas-station
attendants and police officers exposed to low-level benzene [17].
Similar effect sizes on DNA methylation measured in blood
leukocytes from healthy participants have been suggested to
Table 1. Characteristics of 158 Petrochemical Workers and 50 Controls, Bulgaria from 1999– 2000.
Variablesa Workers Controls P-valueb
Sex Male 138 (87.3%) 38 (76%) 0.089
Female 20 (12.7%) 12 (24%)
Age, years 39.9 (8.39) 41.3 (10.8) 0.41
Education level None/Elementary School 13 (8.23%) 2 (4%) ,0.001*
Middle School 121 (76.6%) 21 (42%)
High School and above 24 (15.2%) 27 (54%)
Job-years 13.4 (8.79) 11.1 (10.9) 0.20
Smoking status Current 103 (65.2%) 29 (58%) 0.13
Past 127 (80.4%) 34 (68%)
Never 31 (19.6%) 16 (32%)
Number cigarettes per day 12.7 (11.9) 9.72 (10.3) 0.092
Pack-years 15.3 (15.7) 13.8 (17.5) 0.61
ETS exposure Yes 140 (89.2%) 42 (84%) 0.54
No 17 (10.8%) 8 (16%)
ETS hours 5.32 (4.05) 3.52 (2.41) ,0.001*
% Leukocytes Basophils 0.78 (1.29) 0.34 (0.82) 0.006*
Eosinophils 0.84 (1.49) 1.22 (1.40) 0.11
Monocytes 1.35 (1.47) 1 (1.68) 0.19
Lymphocytes 42.1 (9.44) 41.2 (9.29) 0.60
Neutrophils 53.8 (9.46) 55.3 (8.90) 0.32
Abbreviations: ETS, environmental tobacco smoke.
*P,0.05.
aCategorical variables are expressed as n (%), and continuous variables are expressed as mean (SD).
bP-values were obtained from Pearson’s chi-square test for categorical variables and Welch two-sample t-test for continuous variables and Wilcoxon rank-sum test for
non-normally distribution variables.
doi:10.1371/journal.pone.0050471.t001
Table 2. A Comparison of exposure and methylation variables between workers and controls, Median (IQR).
Variablesa Workers (N=158) Controls (N=50) P-valueb
Min p25 Median (IQR) p75 Max % ,LOD Min p25 Median (IQR) p75 Max % ,LOD
Benzene, ppm 0.012c 0.19 0.46 (1.27) 1.47 23.9 2/158 (1.3%) 0.012c 0.012c 0.012 (0)c 0.012c 0.65 49/50 (98%) 2
SPMA, mg/L 0.24 9.95 15.5 (44.9) 54.9 349.4 0/158 (0%) 0.24 7.73 10.1 (6.6) 14.3 59.7 0/50 (0%) ,0.001*
t,t-MA, mg/L 25.0d 311.5 711 (1270) 1581 9961 13/158 (8.2%) 25.0d 25.0d 25.0 (75.0)d 100 754 33/50 (66%) ,0.001*
Alu, % 22.4 25.1 25.6 (1.03) 26.1 27.2 2 21.9 24.6 25.3 (1.6) 26.2 27.9 2 0.15
LINE-1, % 71.6 80.7 81.8 (1.97) 82.7 85.3 2 75.4 80.5 81.9 (2.23) 82.8 84.3 2 0.72
MAGE, % 47.0 90.4 91.6 (2.16) 92.5 96.4 2 86.2 90.2 91.6 (2.05) 92.3 93.7 2 0.60
p15, % 1.12 2.60 3.32 (1.86) 4.46 14.1 2 1.80 2.87 3.45 (1.23) 4.10 7.65 2 0.78
Abbreviations: SPMA, S-phenylmercapturic acid; t,t-MA, Trans-trans-muconic acid.
Data were missing and excluded in the analysis for the following variables: SPMA (10 individuals), t,t-MA (7 individuals), Alu (14 individuals), LINE-1 (15 individuals),
MAGE (16 individuals) and p15 (28 individuals).
*P,0.05.
aAll exposure and outcome variables are expressed as minimum (Min), 25th quantile (p25), median (IQR), 75th quantile (p75), maximum (Max).
bP-values were obtained from Wilcoxon’s rank sum test.
cAlmost all controls (49/50) have values less than LOD of 0.023 ppm and were assigned a value corresponding to half of LOD in the analysis (i.e. 0.012 ppm).
dA majority of the controls (33/50) have values less than LOD of 50 mg/L and were assigned a value corresponding to half of LOD in the analysis (i.e. 25 mg/l).
doi:10.1371/journal.pone.0050471.t002
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represent an early deviation from normal methylation patterns
induced by benzene exposure [17].
We also found a decrease in p15 methylation in relation to
increasing SPMA levels, contrary to the hypermethylation of p15
reported in the previous investigation by Bollati et al. [17]. Also,
we did not find any significant associations with Alu and MAGE
methylation, which showed a small but significant negative
association with airborne benzene levels in the Bollati et al. study
[17]. Several differences in the levels and sources of exposure
might account for the discrepancies between the two studies.
Bollati et al. studied traffic-exposed subjects in an urban area and
investigated associations of DNA methylation with airborne
benzene levels. In our study instead, we examined a population
of industrial workers with higher workplace exposure levels, and
evaluated associations with urinary biomarkers of benzene
metabolism. The different settings of the exposures, as well as
the different exposure levels may account for the discrepancies in
the results.
This is the first study to compare the use of beta-regression and
OLS regression methods for analyzing proportion methylation
outcomes. We found that beta-regression provided a better
goodness-of-fit, as reflected in higher adjusted pseudo R2 values
and lower AIC values. This finding is consistent with the concept
that beta-regression is more appropriate for analyzing proportion
data, such as DNA methylation, compared to standard linear OLS
regression models. We obtained negative adjusted R2 values for
MAGE in the OLS regression model, because the adjusted R2 takes
into account the number of parameters in the model by
subtracting a function of that number from the value, thus
potentially resulting in negative values in cases of particularly poor
fit [32,33]. Although results from beta-regression were overall
consistent with OLS regression, in beta-regression we found some
significant, but weak, associations of benzene exposure and DNA
methylation which would have been missed by OLS regression.
This finding suggests that beta-regression may be more sensitive
for detecting small changes in percent methylation. This is due to
the more flexible nature of the beta distribution, which unlike the
Gaussian distribution having independent mean and variance
parameters, allows for the mean and the variance to be related,
where the variance is a function of the mean [43]. In fact, being a
member of the exponential family, the beta distribution has a
variance function which directly depends on the mean and, as
such, differences in variance within a variable can be just as
informative as differences in the mean [31]. In addition, beta-
regression allows the use of various link functions linking the
outcome measure to the set of explanatory covariates, allowing
one to fit models with non-linear mean trajectories. Alternatively,
simplex regression can also be used to fit data bounded in (0,1) and
has been shown to give estimates concordant with beta regression
[44].
In the present study, we found associations of urinary SPMA
with DNA methylation markers, whereas no gross methylation
differences were observed between exposed workers and controls.
In general, biomarkers of exposure, including SPMA, are used to
yield more accurate measures of biological dose than occupa-
tional group categories, as they reflect the level of absorption,
metabolism, as well as of the clearance of the chemical. SPMA in
particular, has been previously found to be associated with
oxidative stress [21], a benzene-induced cellular stressor and well-
established modifier of methylation patterns [45]. On the
contrary, we did not observe any significant correlation of t,t-
MA levels with DNA methylation. Previous studies have also
found the correlation of both SPMA and t,t-MA with airborne
benzene to be relatively low and SPMA to be a more reliable
biomarker for benzene exposure due to its longer half-life than
t,t-MA [46–48].
The present study has a number of limitations, including a
relatively small number of participants; and possible unmeasured
confounding, such as non-occupational benzene exposures (e.g.
from vehicle traffic). It should also be noted that other factors that
might affect DNA methylation, such as nutritional factors, were
unmeasured and could not be adjusted for in this study. Our study
has also several strengths including: accurate outcome assessment
with pyrosequencing duplicates completed for each outcome;
biomarkers measured to take into account the internal dose of
each subject with complete data for urinary SPMA; and the use of
a population of workers exposed to high benzene levels which
represents a different setting than those investigated in previous
epigenetic studies. The workers in our population were exposed to
benzene for an average of 13.4 years, and therefore any potential
aberrant changes in methylation if any, caused by chronic benzene
exposure should have been clearly visible after such prolonged
Table 3. Association Estimates of Urinary Biomarkers, SPMA and t,t-MA, on Repeated-element and Gene-Specific Percent
Methylation using OLS Regression.
Unadjusted Adjusteda
Biomarker Outcome Coefficientb P-value Coefficientb P-value R2c AIC
SPMA Alu 0.010 0.72 0.0072 0.83 0.032 444.0
LINE-1 20.089 0.035* 20.14 0.009* 0.054 581.1
MAGE 0.025 0.80 0.011 0.93 20.034 838.7
p15 20.090 0.048* 20.077 0.20 0.021 562.2
t,t-MA Alu 0.027 0.51 0.034 0.48 0.017 486.0
LINE-1 20.054 0.38 20.044 0.56 0.012 633.0
MAGE 0.056 0.71 0.034 0.85 20.025 901.9
p15 0.057 0.39 0.081 0.32 0.011 608.7
Abbreviations: SPMA, S-phenylmercapturic acid; t,t-MA, Trans-trans-muconic acid; AIC, Akaike’s information criterion.
*P,0.05.
aModel adjusted for age, sex, smoking history, education, ETS hours.
bCoefficient refers to the change in methylation % per IQR change in exposure variable.
cAdjusted R2.
doi:10.1371/journal.pone.0050471.t003
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exposure to high levels of benzene. We also considered potential
influences of various leukocyte cell types on between-subject
heterogeneity in the response.
Our findings showed that occupational benzene exposure was
associated with small but statistically significant DNA methylation
changes in the workers. Our results lacked consistency across
Figure 1. Association of S-phenylmercapturic acid (SPMA) with DNA methylation in Alu, LINE-1, MAGE and p15 methylation. Fitted
beta regression models of repeated-element and gene-specific methylation % versus log(SPMA), adjusted for potential confounders as described in
the text. Lines correspond to fitted mean trajectories from beta regression models using the logit link, evaluated for hypothetical individuals with
sample mean covariate values (petrochemical workers, non-smoking male, age: 40, ETS: 5.3 hours, education: middle-school). P-values shown
correspond to main associations of SPMA in each model.
doi:10.1371/journal.pone.0050471.g001
Table 4. Association Estimates of Urinary Biomarkers, SPMA and t,t-MA, on Repeated-element and Gene-Specific Percent
Methylation using Beta-regression.
Unadjusted Adjusteda
Biomarker Outcome Coefficientb P-value Coefficientb P-value R2 c AIC
SPMA Alu 0.010 0.71 0.023 0.41 0.050 2908.0
LINE-1 20.085 0.033* 20.15 0.005* 0.10 2768.6
MAGE 0.010 0.88 20.010 0.81 0.000018 2652.4
p15 20.084 0.023* 20.096 0.001* 0.070 2755.5
t,t-MA Alu 0.028 0.51 0.013 0.70 0.048 2976.0
LINE-1 20.050 0.40 20.0029 0.97 0.056 2834.4
MAGE 0.018 0.86 20.026 0.71 0.0021 2723.0
p15 0.12 0.81 0.11 0.12 0.051 2824.2
Abbreviations: SPMA, S-phenylmercapturic acid; t,t-MA, Trans-trans-muconic acid; AIC, Akaike’s information criterion.
*P,0.05.
aModel adjusted for age, sex, smoking history, education, ETS hours.
bCoefficient refers to the change in methylation % per IQR change in exposure variable.
cPseudo-adjusted R2.
doi:10.1371/journal.pone.0050471.t004
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different biomarkers and exposure metrics and should therefore be
interpreted with caution. Also, some of our findings, such as the
negative associations between SPMA and DNA methylation of
p15, are at variance with previous findings on benzene-exposed
individuals [17]. Because DNA methylation is potentially modi-
fiable through lifestyle and pharmacological interventions, if
confirmed, our findings may open new paths for prevention
against benzene-induced carcinogenesis. If benzene-related hypo-
methylation were to be found to be a mechanistic intermediate
along the path linking benzene to its carcinogenic effects, then
targeted interventions, such as providing benzene-exposed workers
with dietary supplements, including folic acid which may contrast
the association of benzene with DNA hypomethylation [49] could
be developed and tested among benzene-exposed workers.
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